These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
168 related articles for article (PubMed ID: 38603717)
1. The high-density lipoprotein cholesterol (HDL-C)-concentration-dependent association between anti-inflammatory capacity and sepsis: A single-center cross-sectional study. Chen KL; Chou RH; Chang CC; Kuo CS; Wei JH; Huang PH; Lin SJ PLoS One; 2024; 19(4):e0296863. PubMed ID: 38603717 [TBL] [Abstract][Full Text] [Related]
2. Normal HDL Cholesterol Efflux and Anti-Inflammatory Capacities in Type 2 Diabetes Despite Lipidomic Abnormalities. Denimal D; Benanaya S; Monier S; Simoneau I; Pais de Barros JP; Le Goff W; Bouillet B; Vergès B; Duvillard L J Clin Endocrinol Metab; 2022 Aug; 107(9):e3816-e3823. PubMed ID: 35647758 [TBL] [Abstract][Full Text] [Related]
3. Lipoprotein metabolism in patients with severe sepsis. van Leeuwen HJ; Heezius EC; Dallinga GM; van Strijp JA; Verhoef J; van Kessel KP Crit Care Med; 2003 May; 31(5):1359-66. PubMed ID: 12771603 [TBL] [Abstract][Full Text] [Related]
4. Anti-inflammatory function of apolipoprotein B-depleted plasma is impaired in non-alcoholic fatty liver disease. Sarmadi N; Poustchi H; Ali Yari F; Radmard AR; Karami S; Pakdel A; Shabani P; Khaleghian A PLoS One; 2022; 17(4):e0266227. PubMed ID: 35413066 [TBL] [Abstract][Full Text] [Related]
5. The anti-inflammatory function of HDL is impaired in type 2 diabetes: role of hyperglycemia, paraoxonase-1 and low grade inflammation. Ebtehaj S; Gruppen EG; Parvizi M; Tietge UJF; Dullaart RPF Cardiovasc Diabetol; 2017 Oct; 16(1):132. PubMed ID: 29025405 [TBL] [Abstract][Full Text] [Related]
6. High-Density Lipoprotein Anti-Inflammatory Capacity and Incident Cardiovascular Events. Jia C; Anderson JLC; Gruppen EG; Lei Y; Bakker SJL; Dullaart RPF; Tietge UJF Circulation; 2021 May; 143(20):1935-1945. PubMed ID: 33840204 [TBL] [Abstract][Full Text] [Related]
7. Decreased plasma concentrations of apolipoprotein M in sepsis and systemic inflammatory response syndromes. Kumaraswamy SB; Linder A; Åkesson P; Dahlbäck B Crit Care; 2012 Dec; 16(2):R60. PubMed ID: 22512779 [TBL] [Abstract][Full Text] [Related]
8. The anti-inflammatory properties of HDLs are impaired in gout. Wang Y; Wang Y; Jia X; Wang Z; Li X; Mu L; Zhang B Clin Rheumatol; 2021 Apr; 40(4):1525-1531. PubMed ID: 32875512 [TBL] [Abstract][Full Text] [Related]
9. Reconstituted high-density lipoprotein increases plasma high-density lipoprotein anti-inflammatory properties and cholesterol efflux capacity in patients with type 2 diabetes. Patel S; Drew BG; Nakhla S; Duffy SJ; Murphy AJ; Barter PJ; Rye KA; Chin-Dusting J; Hoang A; Sviridov D; Celermajer DS; Kingwell BA J Am Coll Cardiol; 2009 Mar; 53(11):962-71. PubMed ID: 19281927 [TBL] [Abstract][Full Text] [Related]
10. High-Density Lipoprotein-Associated Apolipoprotein M Limits Endothelial Inflammation by Delivering Sphingosine-1-Phosphate to the Sphingosine-1-Phosphate Receptor 1. Ruiz M; Frej C; Holmér A; Guo LJ; Tran S; Dahlbäck B Arterioscler Thromb Vasc Biol; 2017 Jan; 37(1):118-129. PubMed ID: 27879252 [TBL] [Abstract][Full Text] [Related]
11. Vasoprotective Functions of High-Density Lipoproteins Relevant to Alzheimer's Disease Are Partially Conserved in Apolipoprotein B-Depleted Plasma. Button EB; Gilmour M; Cheema HK; Martin EM; Agbay A; Robert J; Wellington CL Int J Mol Sci; 2019 Jan; 20(3):. PubMed ID: 30678190 [TBL] [Abstract][Full Text] [Related]
12. Relationship between liver dysfunction, lipoprotein concentration and mortality during sepsis. Tanaka S; De Tymowski C; Stern J; Bouzid D; Zappella N; Snauwaert A; Robert T; Lortat-Jacob B; Tran-Dinh A; Augustin P; Boutten A; Tashk P; Peoc'h K; Meilhac O; Montravers P PLoS One; 2022; 17(8):e0272352. PubMed ID: 35994439 [TBL] [Abstract][Full Text] [Related]
13. Inhibition of cholesteryl ester transfer protein by anacetrapib does not impair the anti-inflammatory properties of high density lipoprotein. Han S; Levoci L; Fischer P; Wang SP; Gagen K; Chen Y; Xie D; Fisher T; Ehrhardt AG; Peier AM; Johns DG Biochim Biophys Acta; 2013 Apr; 1831(4):825-33. PubMed ID: 23269286 [TBL] [Abstract][Full Text] [Related]
14. Myeloperoxidase level and inflammatory markers and lipid and lipoprotein parameters in stable coronary artery disease. Kimak E; Zięba B; Duma D; Solski J Lipids Health Dis; 2018 Apr; 17(1):71. PubMed ID: 29618370 [TBL] [Abstract][Full Text] [Related]
15. Low HDL levels in sepsis versus trauma patients in intensive care unit. Tanaka S; Labreuche J; Drumez E; Harrois A; Hamada S; Vigué B; Couret D; Duranteau J; Meilhac O Ann Intensive Care; 2017 Dec; 7(1):60. PubMed ID: 28589535 [TBL] [Abstract][Full Text] [Related]
16. Apolipoprotein B vs non-high-density lipoprotein cholesterol: Association with endothelial hemostatic markers and carotid intima-media thickness. Karasek D; Vaverkova H; Cibickova L; Gajdova J; Kubickova V J Clin Lipidol; 2017; 11(2):442-449. PubMed ID: 28502501 [TBL] [Abstract][Full Text] [Related]
17. Non-high-density lipoprotein cholesterol and apolipoprotein B in the prediction of coronary heart disease in men. Pischon T; Girman CJ; Sacks FM; Rifai N; Stampfer MJ; Rimm EB Circulation; 2005 Nov; 112(22):3375-83. PubMed ID: 16316964 [TBL] [Abstract][Full Text] [Related]
18. Serum myeloperoxidase/paraoxonase 1 ratio as potential indicator of dysfunctional high-density lipoprotein and risk stratification in coronary artery disease. Haraguchi Y; Toh R; Hasokawa M; Nakajima H; Honjo T; Otsui K; Mori K; Miyamoto-Sasaki M; Shinohara M; Nishimura K; Ishida T; Hirata K Atherosclerosis; 2014 Jun; 234(2):288-94. PubMed ID: 24704632 [TBL] [Abstract][Full Text] [Related]
19. The apolipoprotein A-I mimetic peptide, ETC-642, reduces chronic vascular inflammation in the rabbit. Di Bartolo BA; Vanags LZ; Tan JT; Bao S; Rye KA; Barter PJ; Bursill CA Lipids Health Dis; 2011 Nov; 10():224. PubMed ID: 22128776 [TBL] [Abstract][Full Text] [Related]
20. Effect of Extended-Release Niacin on High-Density Lipoprotein (HDL) Functionality, Lipoprotein Metabolism, and Mediators of Vascular Inflammation in Statin-Treated Patients. Yadav R; Liu Y; Kwok S; Hama S; France M; Eatough R; Pemberton P; Schofield J; Siahmansur TJ; Malik R; Ammori BA; Issa B; Younis N; Donn R; Stevens A; Durrington P; Soran H J Am Heart Assoc; 2015 Sep; 4(9):e001508. PubMed ID: 26374297 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]